Debt - Additional Information (Detail)
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
|
|
|
|
|
|
|
|
May 22, 2020
USD ($)
|
Apr. 13, 2020
USD ($)
|
Oct. 28, 2019
USD ($)
|
Nov. 09, 2018
USD ($)
d
$ / shares
shares
|
Sep. 27, 2018
USD ($)
$ / shares
|
Sep. 30, 2020
$ / shares
|
Aug. 31, 2020
$ / shares
|
Jul. 31, 2020 |
Mar. 31, 2020
USD ($)
$ / shares
shares
|
Nov. 30, 2019
$ / shares
|
Mar. 31, 2021
USD ($)
$ / shares
shares
|
Mar. 31, 2020
USD ($)
$ / shares
shares
|
Jun. 30, 2020
$ / shares
|
Feb. 24, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Jul. 23, 2020
USD ($)
shares
|
Apr. 14, 2020
USD ($)
|
Dec. 31, 2019
$ / shares
|
May 31, 2019
$ / shares
|
Sep. 11, 2018
$ / shares
shares
|
Mar. 06, 2018
USD ($)
$ / shares
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock value |
|
|
|
|
|
|
|
|
|
|
$ 149,000
|
|
|
|
$ 98,000
|
$ 1,000
|
|
|
|
|
|
EBITDA target |
|
|
|
|
|
|
|
|
|
|
$ (6,062,000)
|
$ (5,352,000)
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares issued | shares |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
1,000
|
|
|
|
|
|
|
Preferred stock par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
$ 0.001
|
|
|
|
|
|
|
Non current term loans |
|
|
|
|
|
|
|
|
|
|
$ 16,295,000
|
|
|
|
$ 16,186,000
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
|
|
|
|
|
$ 600,000
|
$ 600,000
|
|
|
|
|
|
|
|
|
|
Weighted-average interest rate |
|
|
|
|
|
|
|
|
|
|
12.25%
|
|
|
|
|
|
|
|
|
|
|
Warrants adjusted exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.60
|
|
|
|
|
|
|
|
|
Series F Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,000
|
|
|
|
|
|
SWK Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants adjusted strike price | $ / shares |
|
|
|
|
|
|
|
|
$ 0.49
|
$ 1.00
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock | shares |
|
|
|
|
|
|
|
|
487,198
|
|
|
487,198
|
|
|
|
|
|
|
|
|
|
Initial exercise price of warrants | $ / shares |
|
|
|
$ 1.34
|
|
|
|
|
$ 0.39198
|
|
|
$ 0.39198
|
|
|
|
|
|
|
|
$ 1.34
|
|
Warrants expire date |
|
|
|
Nov. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of trading days of average closing price of common stock | d |
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiration period |
|
|
|
8 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, expected volatility rate |
|
|
|
81.79%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions annual dividend per share | $ / shares |
|
|
|
$ 0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, risk-free interest rate |
|
|
|
3.13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, estimated fair value |
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional Warrants issued to purchase shares of common stock | shares |
|
|
|
|
|
|
|
|
63,779
|
|
|
63,779
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrants |
|
|
|
400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants effective-interest method amortization period |
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
DPG Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finder's fee |
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
Nov. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class Of Warrant Or Rights Expiration Date |
|
|
|
Nov. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of trading days of average closing price of common stock | d |
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiration period |
|
|
|
8 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, expected volatility rate |
|
|
|
81.79%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions annual dividend per share | $ / shares |
|
|
|
$ 0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, risk-free interest rate |
|
|
|
3.13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, estimated fair value |
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrants |
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted exercise price of warrants | $ / shares |
|
|
|
|
|
$ 0.62
|
$ 0.38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DPG Warrants | Warrants Issued on November 9, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.8767
|
|
$ 1.34
|
|
DPG Warrants | Warrants Issued on May, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.4197
|
$ 2.17
|
|
|
Original Western Alliance Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.35
|
Western Alliance Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial exercise price of warrants | $ / shares |
|
|
|
|
$ 2.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
|
Sep. 27, 2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PPP Loan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non current term loans |
|
|
|
|
|
|
|
|
|
|
$ 2,980,000
|
|
|
|
2,980,000
|
|
|
|
|
|
|
EIDL Loan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note interest rate per annum |
3.75%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non current term loans |
|
|
|
|
|
|
|
|
|
|
150,000
|
|
|
|
150,000
|
|
|
|
|
|
|
Loan principal amount |
$ 150,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan interest rate per annum |
3.75%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan periodic payment terms |
installment payments, including principal and interest, are due monthly beginning in July 2021 and are
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan balance payment terms |
payable through July 2050.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum | SWK Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock | shares |
|
|
|
372,023,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, estimated fair value |
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrants |
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum | DPG Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
279,851
|
|
Maximum | Original Western Alliance Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock equal value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 120,000
|
Maximum | Western Alliance Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock equal value |
|
|
|
|
$ 120,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum | PPP Loan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonpayroll costs eligible for loan forgiveness percentage |
|
|
|
|
|
|
|
40.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum | PPP Loan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonpayroll costs eligible for loan forgiveness percentage |
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pacific Mercantile Bank | PPP Loan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan granted amount from bank |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,980,000
|
|
|
|
|
Note issued date |
|
Apr. 13, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note maturity date |
|
Apr. 13, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note interest rate per annum |
|
1.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note payable commencing date |
|
Nov. 01, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note prepayment penalties |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non current term loans |
|
|
|
|
|
|
|
|
|
|
3,000,000.0
|
|
|
|
3,000,000.0
|
|
|
|
|
|
|
Loan interest rate per annum |
|
1.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SWK Loan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayments of lines of credit |
|
|
|
$ 700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility term |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings under lines of credit |
|
|
|
$ 14,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, principal repayments beginning term |
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, maturity term |
|
|
|
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non current term loans |
|
|
|
|
|
|
|
|
|
|
14,300,000
|
|
|
|
14,300,000
|
|
|
|
|
|
|
SWK Loan | LIBOR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility interest rate description |
|
|
|
plus 10% or another index that approximates LIBOR as close as possible if and when LIBOR no longer exists.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility bearing floating interest rate per annum |
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SWK Loan | Credit Agreement, Seventh Amendment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incremental amendment fee |
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
SWK Loan | Maximum | Credit Agreement, Seventh Amendment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument covenants unencumbered liquid assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
SWK Loan | Minimum | Credit Agreement, Seventh Amendment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument covenants unencumbered liquid assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
Loan Agreement | Pacific Mercantile Bank |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility, maximum borrowing capacity |
|
|
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum borrowing base percentage of eligible accounts |
|
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum borrowing base percentage of eligible inventory |
|
|
75.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility expiration date |
|
|
Oct. 28, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
1.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit, outstanding borrowings |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
Line of credit facility, unused availability |
|
|
|
|
|
|
|
|
|
|
$ 2,200,000
|
|
|
|
$ 2,300,000
|
|
|
|
|
|
|
Loan Agreement | Pacific Mercantile Bank | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
6.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan Agreement | Exim Bank |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit facility initial and annual fee |
|
|
$ 52,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|